Myoung Ki Jeong

Title: Myoung Ki Jeong: Innovator in Pharmaceutical Formulations

Introduction

Myoung Ki Jeong is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination formulations aimed at treating cardiovascular disorders. His innovative approach has led to the creation of a unique pharmaceutical formulation that combines multiple active ingredients.

Latest Patents

Myoung Ki Jeong holds a patent for a pharmaceutical combination formulation comprising amlodipine, losartan, and rosuvastatin. This formulation features a first discrete part containing amlodipine and rosuvastatin, and a second discrete part containing losartan. The invention is designed to improve the dissolution rate and stability of the active ingredients. The combination formulation effectively minimizes interactions among the active ingredients, making it particularly useful in the pharmaceutical industry for preventing or treating cardiovascular disorders.

Career Highlights

Myoung Ki Jeong is associated with Hanmi Pharm. Co., Ltd., a leading pharmaceutical company in South Korea. His work focuses on developing innovative solutions that enhance the efficacy and stability of pharmaceutical products. His contributions have been instrumental in advancing the field of cardiovascular treatments.

Collaborations

Myoung Ki Jeong has collaborated with notable colleagues, including Ho Taek Im and Yong Il Kim. These collaborations have fostered a productive environment for innovation and have led to significant advancements in pharmaceutical formulations.

Conclusion

Myoung Ki Jeong's work exemplifies the importance of innovation in the pharmaceutical industry. His patented formulation represents a significant step forward in the treatment of cardiovascular disorders, showcasing the potential of combining different active ingredients for improved patient outcomes.